Conmed (CNMD) Other Non-Current Liabilities (2010 - 2026)

Conmed's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $63.0 million for Q1 2026.

• Quarterly Other Non-Current Liabilities fell 16.53% year-over-year to $63.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.0 million (down 16.53% YoY) and the FY2025 annual result came in at $63.9 million, down 26.01% from the prior year.
• Other Non-Current Liabilities was $63.0 million for Q1 2026 at Conmed, down from $63.9 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $218.1 million in Q3 2022 and bottomed at $41.8 million in Q1 2022.
• A 5-year average of $113.4 million and a median of $107.3 million in 2024 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 373.8% — and 2024, when it tumbled 41.41%.
• Conmed's Other Non-Current Liabilities stood at $203.7 million in 2022, then sank by 40.58% to $121.0 million in 2023, then retreated by 28.7% to $86.3 million in 2024, then declined by 26.01% to $63.9 million in 2025, then declined by 1.3% to $63.0 million in 2026.
• Business Quant data shows CNMD's Other Non-Current Liabilities at $63.0 million in Q1 2026, $63.9 million in Q4 2025, and $71.7 million in Q3 2025.